Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03735992
What this trial is testing

Mind-body Medicine for Patients With Malignant Hematological Diseases

Who this might be right for
Hematologic Neoplasms
Universität Duisburg-Essen 94
Not applicableEnded earlyNCT00176930
What this trial is testing

Stem Cell Transplant for Hematological Malignancy

Who this might be right for
Leukemia, Myeloid, ChronicAMLLeukemia, Lymphocytic, Acute+6 more
Masonic Cancer Center, University of Minnesota 330
Not applicableUnknownNCT05780411
What this trial is testing

Cancer Survivorship in Hematologic Malignancies

Who this might be right for
Cancer Survivors
Assiut University 80
Not applicableStudy completedNCT06689332
What this trial is testing

Improving Quality of Life in Frail, Older Patients with Hematological Cancer Through Geriatric Assessment and Treatment - a Pilot Study

Who this might be right for
Hematological CancersFrailtyELDERLY PEOPLE
Odense University Hospital 17
Not applicableLooking for participantsNCT07035938
What this trial is testing

T-cell Developmental Status in Patients With Malignant Hematological Tumors

Who this might be right for
Hematologic Malignancy
The First Affiliated Hospital of Xiamen University 75
Post-approval studies (Phase 4)Study completedNCT07811856
What this trial is testing

Effects of Metformin and Theory-Based Education in Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome (PCOS) Women
Jerash Private University 900
Early research (Phase 1)UnknownNCT04412577
What this trial is testing

TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Relapsed/Refractory Hematological Malignancies
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 57
Early research (Phase 1)Looking for participantsNCT06801002
What this trial is testing

Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

Who this might be right for
Solid Tumor
Jabez Bioscience, Inc 25
Large-scale testing (Phase 3)Study completedNCT05290545
What this trial is testing

Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT

Who this might be right for
Hematological MalignanciesHematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 314
Testing effectiveness (Phase 2)Ended earlyNCT05579769
What this trial is testing

Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.

Who this might be right for
Hematologic MalignancyMyeloid Malignancy
St. Jude Children's Research Hospital 3
Not applicableLooking for participantsNCT06829654
What this trial is testing

Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors

Who this might be right for
SarcomasHaematological Malignancies
IRCCS Azienda Ospedaliero-Universitaria di Bologna 80
Not applicableStudy completedNCT05236296
What this trial is testing

Emotion and Symptom-focused Engagement for Caregivers (EASE-CG) Pilot Study

Who this might be right for
Leukemia, Acute
University Health Network, Toronto 40
Testing effectiveness (Phase 2)Looking for participantsNCT05092451
What this trial is testing

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Who this might be right for
B-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more
M.D. Anderson Cancer Center 80
Not applicableStudy completedNCT01021683
What this trial is testing

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Who this might be right for
Hematologic NeoplasmsNeutropeniaFever
Janssen Korea, Ltd., Korea 203
Not applicableEnded earlyNCT01685411
What this trial is testing

Busulfan and Cyclophosphamide Followed By ALLO BMT

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 5
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableActive Not RecruitingNCT04142372
What this trial is testing

Tissue Microarray of Hematological Malignancies

Who this might be right for
Hematological Malignancies
Tampere University Hospital 5,000
Not applicableLooking for participantsNCT05475600
What this trial is testing

APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU

Who this might be right for
Adapted Physical ActivityHematological MalignanciesAnxiety+1 more
Centre Hospitalier Régional Metz-Thionville 90
Early research (Phase 1)Study completedNCT02240719
What this trial is testing

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Grade 1 Follicular Lymphoma+5 more
University of California, Davis 20
Not applicableStudy completedNCT00440765
What this trial is testing

VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

Who this might be right for
Multiple MyelomaHematological Neoplasms
Janssen-Cilag B.V. 331
Next Page